Getting the Message. Direct Manipulation of Host mRNA Accumulation During Gammaherpesvirus Lytic Infection

Advances in Virus Research

Volumn 78, Issue C, 2010, Pages 1-42

  Clyde, Karen ^a   Glaunsinger, Britt A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ANIMAL; BOOK; CLASSIFICATION; GAMMAHERPESVIRINAE; GENE EXPRESSION REGULATION; GENETICS; HERPES VIRUS INFECTION; HOST PATHOGEN INTERACTION; HUMAN; METABOLISM; PHYLOGENY; PHYSIOLOGY; VIROLOGY; VIRUS REPLICATION;

ANIMALS; GAMMAHERPESVIRINAE; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRIDAE INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; PHYLOGENY; RNA, MESSENGER; VIRUS REPLICATION;

EID: 78049383614     PISSN: 00653527     EISSN: 15578399     Source Type: Book Series    
DOI: 10.1016/B978-0-12-385032-4.00001-X     Document Type: Book

References (198)

1. Adams P.D., Sellers W.R., Sharma S.K., Wu A.D., Nalin C.M., Kaelin W.G. Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors. Mol. Cell. Biol. 1996, 16(12):6623-6633.
2. Alvarez G.R., Zwilling B.S., Lafuse W.P. Mycobacterium avium inhibition of IFN-gamma signaling in mouse macrophages: Toll-like receptor 2 stimulation increases expression of dominant-negative STAT1 beta by mRNA stabilization. J. Immunol. 2003, 171(12):6766-6773.
3. Arias C., Walsh D., Harbell J., Wilson A.C., Mohr I. Activation of host translational control pathways by a viral developmental switch. PLoS Pathog. 2009, 5(3):e1000334.
4. Barton E.S., Lutzke M.L., Rochford R., Virgin H.W. Alpha/beta interferons regulate murine gammaherpesvirus latent gene expression and reactivation from latency. J. Virol. 2005, 79(22):14149-14160.
5. Bentz G.L., Liu R., Hahn A.M., Shackelford J., Pagano J.S. Epstein-Barr virus BRLF1 inhibits transcription of IRF3 and IRF7 and suppresses induction of interferon-beta. Virology 2010, 402(1):121-128.
6. Blakqori G., van Knippenberg I., Elliott R.M. Bunyamwera orthobunyavirus S-segment untranslated regions mediate poly(A) tail-independent translation. J. Virol. 2009, 83(8):3637-3646.
7. Boyne J.R., Colgan K.J., Whitehouse A. Herpesvirus saimiri ORF57: A post-transcriptional regulatory protein. Front. Biosci. 2008, 13:2928-2938.
8. Boyne J.R., Jackson B.R., Taylor A., Macnab S.A., Whitehouse A. Kaposi's sarcoma-associated herpesvirus ORF57 protein interacts with PYM to enhance translation of viral intronless mRNAs. EMBO J. 2010, 29(11):1851-1864.
9. Brown H.J., Song M.J., Deng H., Wu T.T., Cheng G., Sun R. NF-kappaB inhibits gammaherpesvirus lytic replication. J. Virol. 2003, 77(15):8532-8540.
10. Brown H.J., Peng L., Harada J.N., Walker J.R., Cole S., Lin S.F., Zack J.A., Chanda S.K., Sun R. Gene expression and transcription factor profiling reveals inhibition of transcription factor CREB by gamma-herpesvirus replication and transcription activator(RTA). J. Biol. Chem. 2010, 285(33):25139-25153.
11. Buisson M., Geoui T., Flot D., Tarbouriech N., Ressing M.E., Wiertz E.J., Burmeister W.P. A bridge crosses the active-site canyon of the Epstein-Barr virus nuclease with DNase and RNase activities. J. Mol. Biol. 2009, 391(4):717-728.
12. Carroll K.D., Bu W., Palmeri D., Spadavecchia S., Lynch S.J., Marras S.A., Tyagi S., Lukac D.M. Kaposi's Sarcoma-associated herpesvirus lytic switch protein stimulates DNA binding of RBP-Jk/CSL to activate the Notch pathway. J. Virol. 2006, 80(19):9697-9709.
13. Cayrol C., Flemington E.K. Identification of cellular target genes of the Epstein-Barr virus transactivator Zta: Activation of transforming growth factor beta igh3 (TGF-beta igh3) and TGF-beta 1. J. Virol. 1995, 69(7):4206-4212.
14. Cayrol C., Flemington E.K. The Epstein-Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors. EMBO J. 1996, 15(11):2748-2759.
15. Chandriani S., Ganem D. Host transcript accumulation during lytic KSHV infection reveals several classes of host responses. PLoS ONE 2007, 2(8):e811.
16. Chang J., Renne R., Dittmer D., Ganem D. Inflammatory cytokines and the reactivation of Kaposi's sarcoma-associated herpesvirus lytic replication. Virology 2000, 266(1):17-25.
17. Chang H., Gwack Y., Kingston D., Souvlis J., Liang X., Means R.E., Cesarman E., Hutt-Fletcher L., Jung J.U. Activation of CD21 and CD23 gene expression by Kaposi's sarcoma-associated herpesvirus RTA. J. Virol. 2005, 79(8):4651-4663.
18. Chang L.K., Chung J.Y., Hong Y.R., Ichimura T., Nakao M., Liu S.T. Activation of Sp1-mediated transcription by Rta of Epstein-Barr virus via an interaction with MCAF1. Nucleic Acids Res. 2005, 33(20):6528-6539.
19. Chang Y., Lee H.H., Chen Y.T., Lu J., Wu S.Y., Chen C.W., Takada K., Tsai C.H. Induction of the early growth response 1 gene by Epstein-Barr virus lytic transactivator Zta. J. Virol. 2006, 80(15):7748-7755.
20. Chang S.S., Lo Y.C., Chua H.H., Chiu H.Y., Tsai S.C., Chen J.Y., Lo K.W., Tsai C.H. Critical role of p53 in histone deacetylase inhibitor-induced Epstein-Barr virus Zta expression. J. Virol. 2008, 82(15):7745-7751.
21. Chang P.C., Izumiya Y., Wu C.Y., Fitzgerald L.D., Campbell M., Ellison T.J., Lam K.S., Luciw P.A., Kung H.J. Kaposi's sarcoma-associated herpesvirus (KSHV) encodes a SUMO E3 ligase that is SIM-dependent and SUMO-2/3-specific. J. Biol. Chem. 2010, 285(8):5266-5273.
22. Chen Y.L., Chen Y.J., Tsai W.H., Ko Y.C., Chen J.Y., Lin S.F. The Epstein-Barr virus replication and transcription activator, Rta/BRLF1, induces cellular senescence in epithelial cells. Cell Cycle 2009, 8(1):58-65.
23. Chua H.H., Yeh T.H., Wang Y.P., Huang Y.T., Sheen T.S., Lo Y.C., Chou Y.C., Tsai C.H. Upregulation of discoidin domain receptor 2 in nasopharyngeal carcinoma. Head Neck 2008, 30(4):427-436.
24. Conrad N.K. Posttranscriptional gene regulation in Kaposi's sarcoma-associated herpesvirus. Adv. Appl. Microbiol. 2009, 68:241-261.
25. Coscoy L., Ganem D. Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proc. Natl. Acad. Sci. USA 2000, 97(14):8051-8056.
26. Covarrubias S., Richner J.M., Clyde K., Lee Y.J., Glaunsinger B.A. Host shutoff is a conserved phenotype of gammaherpesvirus infection and is orchestrated exclusively from the cytoplasm. J. Virol. 2009, 83(18):9554-9566.
27. Croft N.P., Shannon-Lowe C., Bell A.I., Horst D., Kremmer E., Ressing M.E., Wiertz E.J., Middeldorp J.M., Rowe M., Rickinson A.B., Hislop A.D. Stage-specific inhibition of MHC class I presentation by the Epstein-Barr virus BNLF2a protein during virus lytic cycle. PLoS Pathog. 2009, 5(6):e1000490.
28. Dahlroth S.L., Gurmu D., Haas J., Erlandsen H., Nordlund P. Crystal structure of the shutoff and exonuclease protein from the oncogenic Kaposi's sarcoma-associated herpesvirus. FEBS J. 2009, 276(22):6636-6645.
29. Damania B. DNA tumor viruses and human cancer. Trends Microbiol. 2007, 15(1):38-44.
30. Deng H., Chu J.T., Rettig M.B., Martinez-Maza O., Sun R. Rta of the human herpesvirus 8/Kaposi sarcoma-associated herpesvirus up-regulates human interleukin-6 gene expression. Blood 2002, 100(5):1919-1921.
31. Di Renzo L., Avila-Carino J., Klein E. Induction of the lytic viral cycle in Epstein Barr virus carrying Burkitt lymphoma lines is accompanied by increased expression of major histocompatibility complex molecules. Immunol. Lett. 1993, 38(3):207-214.
32. Dobrikova E., Shveygert M., Walters R., Gromeier M. Herpes simplex virus proteins ICP27 and UL47 associate with polyadenylate-binding protein and control its subcellular distribution. J. Virol. 2010, 84(1):270-279.
33. Doorbar J. The papillomavirus life cycle. J. Clin. Virol. 2005, 32(Suppl 1):S7-S15.
34. Dreyfus D.H., Nagasawa M., Pratt J.C., Kelleher C.A., Gelfand E.W. Inactivation of NF-kappaB by EBV BZLF-1-encoded ZEBRA protein in human T cells. J. Immunol. 1999, 163(11):6261-6268.
35. Drozina G., Kohoutek J., Jabrane-Ferrat N., Peterlin B.M. Expression of MHC II genes. Curr. Top. Microbiol. Immunol. 2005, 290:147-170.
36. Ebrahimi B., Dutia B.M., Roberts K.L., Garcia-Ramirez J.J., Dickinson P., Stewart J.P., Ghazal P., Roy D.J., Nash A.A. Transcriptome profile of murine gammaherpesvirus-68 lytic infection. J. Gen. Virol. 2003, 84(Pt 1):99-109.
37. Elgadi M.M., Smiley J.R. Picornavirus internal ribosome entry site elements target RNA cleavage events induced by the herpes simplex virus virion host shutoff protein. J. Virol. 1999, 73(11):9222-9231.
38. Ellenberger T. Getting a grip on DNA recognition-Structures of the basic region leucine-zipper, and the basic region helix-loop-helix DNA-binding domains. Curr. Opin. Struct. Biol. 1994, 4(1):12-21.
39. Ertesvag A., Aasheim H.C., Naderi S., Blomhoff H.K. Vitamin A potentiates CpG-mediated memory B-cell proliferation and differentiation: Involvement of early activation of p38MAPK. Blood 2007, 109(9):3865-3872.
40. Farrell P.J. Signal transduction from the Epstein-Barr virus LMP-1 transforming protein. Trends Microbiol. 1998, 6(5):175-177. discussion 177-8.
41. Farrell P.J., Rowe D.T., Rooney C.M., Kouzarides T. Epstein-Barr virus BZLF1 trans-activator specifically binds to a consensus AP-1 site and is related to c-fos. EMBO J. 1989, 8(1):127-132.
42. Feederle R., Bannert H., Lips H., Muller-Lantzsch N., Delecluse H.J. The Epstein-Barr virus alkaline exonuclease BGLF5 serves pleiotropic functions in virus replication. J. Virol. 2009, 83(10):4952-4962.
43. Feng P., Everly D.N., Read G.S. mRNA decay during herpesvirus infections: Interaction between a putative viral nuclease and a cellular translation factor. J. Virol. 2001, 75(21):10272-10280.
44. Feng P., Everly D.N., Read G.S. mRNA decay during herpes simplex virus (HSV) infections: Protein-protein interactions involving the HSV virion host shutoff protein and translation factors eIF4H and eIF4A. J. Virol. 2005, 79(15):9651-9664.
45. Foussat A., Wijdenes J., Bouchet L., Gaidano G., Neipel F., Balabanian K., Galanaud P., Couderc J., Emilie D. Human interleukin-6 is in vivo an autocrine growth factor for human herpesvirus-8-infected malignant B lymphocytes. Eur. Cytokine Netw. 1999, 10(4):501-508.
46. Fu M., Zhu X., Zhang J., Liang J., Lin Y., Zhao L., Ehrengruber M.U., Chen Y.E. Egr-1 target genes in human endothelial cells identified by microarray analysis. Gene 2003, 315:33-41.
47. Fujita N., Watanabe S., Ichimura T., Ohkuma Y., Chiba T., Saya H., Nakao M. MCAF mediates MBD1-dependent transcriptional repression. Mol. Cell. Biol. 2003, 23(8):2834-2843.
48. Ganem D. Kaposi's sarcoma-associated herpesvirus. Fields Virology 2007, Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia. 5th Edn. B.N. Fields, D.M. Knipe, P.M. Howley (Eds.).
49. Ganem D. KSHV and the pathogenesis of Kaposi sarcoma: Listening to human biology and medicine. J. Clin. Investig. 2010, 120(4):939-949.
50. Ganem D., Ziegelbauer J. MicroRNAs of Kaposi's sarcoma-associated herpes virus. Semin. Cancer Biol. 2008, 18(6):437-440.
51. Gannage M., Munz C. Autophagy in MHC class II presentation of endogenous antigens. Curr. Top. Microbiol. Immunol. 2009, 335:123-140.
52. Glaunsinger B., Ganem D. Highly selective escape from KSHV-mediated host mRNA shutoff and its implications for viral pathogenesis. J. Exp. Med. 2004, 200(3):391-398.
53. Glaunsinger B., Ganem D. Lytic KSHV infection inhibits host gene expression by accelerating global mRNA turnover. Mol. Cell 2004, 13(5):713-723.
54. Glaunsinger B.A., Ganem D.E. Messenger RNA turnover and its regulation in herpesviral infection. Adv. Virus Res. 2006, 66:337-394.
55. Glaunsinger B.A., Lee Y.J. How tails define the ending: Divergent roles for polyadenylation in RNA stability and gene expression. RNA Biol. 2010, 7(1).
56. Glaunsinger B., Chavez L., Ganem D. The exonuclease and host shutoff functions of the SOX protein of Kaposi's sarcoma-associated herpesvirus are genetically separable. J. Virol. 2005, 79(12):7396-7401.
57. Gould F., Harrison S.M., Hewitt E.W., Whitehouse A. Kaposi's sarcoma-associated herpesvirus RTA promotes degradation of the Hey1 repressor protein through the ubiquitin proteasome pathway. J. Virol. 2009, 83(13):6727-6738.
58. Guo Q., Qian L., Guo L., Shi M., Chen C., Lv X., Yu M., Hu M., Jiang G., Guo N. Transactivators Zta and Rta of Epstein-Barr virus promote G0/G1 to S transition in Raji cells: A novel relationship between lytic virus and cell cycle. Mol. Immunol. 2010, 47(9):1783-1792.
59. Gupta A.K., Ruvolo V., Patterson C., Swaminathan S. The human herpesvirus 8 homolog of Epstein-Barr virus SM protein (KS-SM) is a posttranscriptional activator of gene expression. J. Virol. 2000, 74(2):1038-1044.
60. Gutsch D.E., Holley-Guthrie E.A., Zhang Q., Stein B., Blanar M.A., Baldwin A.S., Kenney S.C. The bZIP transactivator of Epstein-Barr virus, BZLF1, functionally and physically interacts with the p65 subunit of NF-kappa B. Mol. Cell. Biol. 1994, 14(3):1939-1948.
61. Gutsch D.E., Marcu K.B., Kenney S.C. The Epstein-Barr virus BRLF1 gene product transactivates the murine and human c-myc promoters. Cell. Mol. Biol. (Noisy-le-grand) 1994, 40(6):747-760.
62. Gwack Y., Hwang S., Lim C., Won Y.S., Lee C.H., Choe J. Kaposi's Sarcoma-associated herpesvirus open reading frame 50 stimulates the transcriptional activity of STAT3. J. Biol. Chem. 2002, 277(8):6438-6442.
63. Hahn A.M., Huye L.E., Ning S., Webster-Cyriaque J., Pagano J.S. Interferon regulatory factor 7 is negatively regulated by the Epstein-Barr virus immediate-early gene, BZLF-1. J. Virol. 2005, 79(15):10040-10052.
64. Hair J.R., Lyons P.A., Smith K.G.C., Efstathiou S. Control of Rta expression critically determines transcription of viral and cellular genes following gammaherpesvirus infection. J. Gen. Virol. 2007, 88:1689-1697.
65. Harb M., Becker M.M., Vitour D., Baron C.H., Vende P., Brown S.C., Bolte S., Arold S.T., Poncet D. Nuclear localization of cytoplasmic poly(A)-binding protein upon rotavirus infection involves the interaction of NSP3 with eIF4G and RoXaN. J. Virol. 2008, 82(22):11283-11293.
66. Hayward S.D., Liu J., Fujimuro M. Notch and Wnt signaling: Mimicry and manipulation by gamma herpesviruses. Sci. STKE 2006, 335:re4.
67. Heather J., Flower K., Isaac S., Sinclair A.J. The Epstein-Barr virus lytic cycle activator Zta interacts with methylated ZRE in the promoter of host target gene egr1. J. Gen. Virol. 2009, 90(Pt 6):1450-1454.
68. Herbein G., O'Brien W.A. Tumor necrosis factor (TNF)-alpha and TNF receptors in viral pathogenesis. Proc. Soc. Exp. Biol. Med. 2000, 223(3):241-257.
69. Hilleren P., Parker R. Defects in the mRNA export factors Rat7p, Gle1p, Mex67p, and Rat8p cause hyperadenylation during 3'-end formation of nascent transcripts. RNA 2001, 7(5):753-764.
70. Ho C.H., Hsu C.F., Fong P.F., Tai S.K., Hsieh S.L., Chen C.J. Epstein-Barr virus transcription activator Rta upregulates decoy receptor 3 expression by binding to its prornoter. J. Virol. 2007, 81(9):4837-4847.
71. Hsu M., Wu S.Y., Chang S.S., Su I.J., Tsai C.H., Lai S.J., Shiau A.L., Takada K., Chang Y. Epstein-Barr virus lytic transactivator Zta enhances chemotactic activity through induction of interleukin-8 in nasopharyngeal carcinoma cells. J. Virol. 2008, 82(7):3679-3688.
72. Hwang S., Gwack Y., Byun H., Lim C., Choe J. The Kaposi's sarcoma-associated herpesvirus K8 protein interacts with CREB-binding protein (CBP) and represses CBP-mediated transcription. J. Virol. 2001, 75(19):9509-9516.
73. Hwang S., Lee D., Gwack Y., Min H., Choe J. Kaposi's sarcoma-associated herpesvirus K8 protein interacts with hSNF5. J. Gen. Virol. 2003, 84(Pt 3):665-676.
74. Izumiya Y., Lin S.F., Ellison T.J., Levy A.M., Mayeur G.L., Izumiya C., Kung H.J. Cell cycle regulation by Kaposi's sarcoma-associated herpesvirus K-bZIP: Direct interaction with cyclin-CDK2 and induction of G(1) growth arrest. J. Virol. 2003, 77(17):9652-9661.
75. Izumiya Y., Ellison T.J., Yeh E.T., Jung J.U., Luciw P.A., Kung H.J. Kaposi's sarcoma-associated herpesvirus K-bZIP represses gene transcription via SUMO modification. J. Virol. 2005, 79(15):9912-9925.
76. Izumiya Y., Izumiya C., Van Geelen A., Wang D.H., Lam K.S., Luciw P.A., Kung H.J. Kaposi's sarcoma-associated herpesvirus-encoded protein kinase and its interaction with K-bZIP. J. Virol. 2007, 81(3):1072-1082.
77. Izumiya Y., Izumiya C., Hsia D., Ellison T.J., Luciw P.A., Kung H.J. NF-kappaB serves as a cellular sensor of Kaposi's sarcoma-associated herpesvirus latency and negatively regulates K-Rta by antagonizing the RBP-Jkappa coactivator. J. Virol. 2009, 83(9):4435-4446.
78. Jackson R.J., Hellen C.U., Pestova T.V. The mechanism of eukaryotic translation initiation and principles of its regulation. Nat. Rev. Mol. Cell Biol. 2010, 11(2):113-127.
79. Jensen T.H., Patricio K., McCarthy T., Rosbash M. A block to mRNA nuclear export in S. cerevisiae leads to hyperadenylation of transcripts that accumulate at the site of transcription. Mol. Cell 2001, 7(4):887-898.
80. Jham B.C., Montaner S. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor: Lessons on dysregulated angiogenesis from a viral oncogene. J. Cell. Biochem. 2010, 110(1):1-9.
81. Johnson P.F. Molecular stop signs: Regulation of cell-cycle arrest by C/EBP transcription factors. J. Cell Sci. 2005, 118(Pt 12):2545-2555.
82. Jones R.J., Dickerson S., Bhende P.M., Delecluse H.J., Kenney S.C. Epstein-Barr virus lytic infection induces retinoic acid-responsive genes through induction of a retinol-metabolizing enzyme, DHRS9. J. Biol. Chem. 2007, 282(11):8317-8324.
83. Jones R.J., Seaman W.T., Feng W.H., Barlow E., Dickerson S., Delecluse H.J., Kenney S.C. Roles of lytic viral infection and IL-6 in early versus late passage lymphoblastoid cell lines and EBV-associated lymphoproliferative disease. Int. J. Cancer 2007, 121(6):1274-1281.
84. Keating S., Prince S., Jones M., Rowe M. The lytic cycle of Epstein-Barr virus is associated with decreased expression of cell surface major histocompatibility complex class I and class II molecules. J. Virol. 2002, 76(16):8179-8188.
85. Kehm E., Goksu M., Bayer S., Knopf C.W. Herpes simplex virus type 1 DNase: Functional analysis of the enzyme expressed by recombinant baculovirus. Intervirology 1998, 41(2-3):110-119.
86. Kessenbrock K., Plaks V., Werb Z. Matrix metalloproteinases: Regulators of the tumor microenvironment. Cell 2010, 141(1):52-67.
87. Kieff E., Rickinson A.B. Epstein-Barr virus and its replication. Fields Virology 2007, Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia. 5th Edn. B.N. Fields, D.M. Knipe, P.M. Howley (Eds.).
88. Kirshner J.R., Lukac D.M., Chang J., Ganem D. Kaposi's sarcoma-associated herpesvirus open reading frame 57 encodes a posttranscriptional regulator with multiple distinct activities. J. Virol. 2000, 74(8):3586-3597.
89. Knopf C.W., Weisshart K. Comparison of exonucleolytic activities of herpes simplex virus type-1 DNA polymerase and DNase. Eur. J. Biochem. 1990, 191(2):263-273.
90. Kovall R.A., Matthews B.W. Structural, functional, and evolutionary relationships between lambda-exonuclease and the type II restriction endonucleases. Proc. Natl. Acad. Sci. USA 1998, 95(14):7893-7897.
91. Krug L.T., Moser J.M., Dickerson S.M., Speck S.H. Inhibition of NF-kappaB activation in vivo impairs establishment of gammaherpesvirus latency. PLoS Pathog. 2007, 3(1):e11.
92. Kudoh A., Daikoku T., Sugaya Y., Isomura H., Fujita M., Kiyono T., Nishiyama Y., Tsurumi T. Inhibition of S-phase cyclin-dependent kinase activity blocks expression of Epstein-Barr virus immediate-early and early genes, preventing viral lytic replication. J. Virol. 2004, 78(1):104-115.
93. Kumar G.R., Glaunsinger B.A. Nuclear import of cytoplasmic poly(A) binding protein restricts gene expression via hyperadenylation and nuclear retention of messenger RNA. Mol. Cell. Biol. 2010, [Epub ahead of print].
94. Kutok J.L., Wang F. Spectrum of Epstein-Barr virus-associated diseases. Annu. Rev. Pathol. 2006, 1:375-404.
95. Laichalk L.L., Thorley-Lawson D.A. Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J. Virol. 2005, 79(2):1296-1307.
96. Laurent C., Meggetto F., Brousset P. Human herpesvirus 8 infections in patients with immunodeficiencies. Hum. Pathol. 2008, 39(7):983-993.
97. Lee Y.J., Glaunsinger B.A. Aberrant herpesvirus-induced polyadenylation correlates with cellular messenger RNA destruction. PLoS Biol. 2009, 7(5):e1000107.
98. Lefort S., Soucy-Faulkner A., Grandvaux N., Flamand L. Binding of Kaposi's sarcoma-associated herpesvirus K-bZIP to interferon-responsive factor 3 elements modulates antiviral gene expression. J. Virol. 2007, 81(20):10950-10960.
99. Li Q., Verma I.M. NF-kappaB regulation in the immune system. Nat. Rev. Immunol. 2002, 2(10):725-734.
100. Li Y., Mahajan N.P., Webster-Cyriaque J., Bhende P., Hong G.K., Earp H.S., Kenney S. The C-mer gene is induced by Epstein-Barr virus immediate-early protein BRLF1. J. Virol. 2004, 78(21):11778-11785.
101. Li Y., Webster-Cyriaque J., Tomlinson C.C., Yohe M., Kenney S. Fatty acid synthase expression is induced by the Epstein-Barr virus immediate-early protein BRLF1 and is required for lytic viral gene expression. J. Virol. 2004, 78(8):4197-4206.
102. Li T., Santockyte R., Shen R.F., Tekle E., Wang G., Yang D.C., Chock P.B. Expression of SUMO-2/3 induced senescence through p53- and pRB-mediated pathways. J. Biol. Chem. 2006, 281(47):36221-36227.
103. Li D., Qian L., Chen C.G., Shi M., Yu M., Hu M.R., Song L., Shen B.F., Guo N. Down-Regulation of MHC Class II Expression through Inhibition of CIITA Transcription by Lytic Transactivator Zta during Epstein-Barr Virus Reactivation. J. Immunol. 2009, 182(4):1799-1809.
104. Li X., Chen S., Feng J., Deng H., Sun R. Myc is required for the maintenance of Kaposi's sarcoma-associated herpesvirus latency. J. Virol. 2010, 84:8945-8948.
105. Liang C.L., Chen J.L., Hsu Y.P., Ou J.T., Chang Y.S. Epstein-Barr virus BZLF1 gene is activated by transforming growth factor-beta through cooperativity of Smads and c-Jun/c-Fos proteins. J. Biol. Chem. 2002, 277(26):23345-23357.
106. Liang Y.Y., Chang J., Lynch S.J., Lukac D.M., Ganem D. The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-J kappa (CSL), the target of the Notch signaling pathway. Genes Dev. 2002, 16(15):1977-1989.
107. Libri D., Dower K., Boulay J., Thomsen R., Rosbash M., Jensen T.H. Interactions between mRNA export commitment, 3'-end quality control, and nuclear degradation. Mol. Cell. Biol. 2002, 22(23):8254-8266.
108. Lin R., Genin P., Mamane Y., Sgarbanti M., Battistini A., Harrington W.J., Barber G.N., Hiscott J. HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators. Oncogene 2001, 20(7):800-811.
109. Lin Z., Yin Q., Flemington E. Identification of a negative regulatory element in the Epstein-Barr virus Zta transactivation domain that is regulated by the cell cycle control factors c-Myc and E2F1. J. Virol. 2004, 78(21):11962-11971.
110. Lu J., Chen S.Y., Chua H.H., Liu Y.S., Huang Y.T., Chang Y., Chen J.Y., Sheen T.S., Tsai C.H. Upregulation of tyrosine kinase TKT by the Epstein-Barr virus transactivator Zta. J. Virol. 2000, 74(16):7391-7399.
111. Lu J., Chua H.H., Chen S.Y., Chen J.Y., Tsai C.H. Regulation of matrix metalloproteinase-1 by Epstein-Barr virus proteins. Cancer Res. 2003, 63(1):256-262.
112. Mages J., Freimuller K., Lang R., Hatzopoulos A.K., Guggemoos S., Koszinowski U.H., Adler H. Proteins of the secretory pathway govern virus productivity during lytic gammaherpesvirus infection. J. Cell. Mol. Med. 2008, 12(5B):1974-1989.
113. Mahot S., Sergeant A., Drouet E., Gruffat H. A novel function for the Epstein-Barr virus transcription factor EB1/Zta: Induction of transcription of the hIL-10 gene. J. Gen. Virol. 2003, 84(Pt 4):965-974.
114. Mauser A., Holley-Guthrie E., Simpson D., Kaufmann W., Kenney S. The Epstein-Barr virus immediate-early protein BZLF1 induces both a G(2) and a mitotic block. J. Virol. 2002, 76(19):10030-10037.
115. Mauser A., Holley-Guthrie E., Zanation A., Yarborough W., Kaufmann W., Klingelhutz A., Seaman W.T., Kenney S. The Epstein-Barr virus immediate-early protein BZLF1 induces expression of E2F-1 and other proteins involved in cell cycle progression in primary keratinocytes and gastric carcinoma cells. J. Virol. 2002, 76(24):12543-12552.
116. Mauser A., Saito S., Appella E., Anderson C.W., Seaman W.T., Kenney S. The Epstein-Barr virus immediate-early protein BZLF1 regulates p53 function through multiple mechanisms. J. Virol. 2002, 76(24):12503-12512.
117. McCormick C., Ganem D. The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAs. Science 2005, 307(5710):739-741.
118. Mendoza N., Diamantis M., Arora A., Bartlett B., Gewirtzman A., Tremaine A.M., Tyring S. Mucocutaneous manifestations of Epstein-Barr virus infection. Am. J. Clin. Dermatol. 2008, 9(5):295-305.
119. Miller G., El-Guindy A., Countryman J., Ye J., Gradoville L. Lytic cycle switches of oncogenic human gammaherpesviruses. Adv. Cancer Res. 2007, 97:81-109.
120. Modrow S., Wolf H. Herpesvirus saimiri-induced proteins in lytically infected cells I. Time-ordered synthesis. J. Gen. Virol. 1983, 64(Pt 1):37-46.
121. Monini P., Carlini F., Sturzl M., Rimessi P., Superti F., Franco M., Melucci-Vigo G., Cafaro A., Goletti D., Sgadari C., Butto S., Leone P., et al. Alpha interferon inhibits human herpesvirus 8 (HHV-8) reactivation in primary effusion lymphoma cells and reduces HHV-8 load in cultured peripheral blood mononuclear cells. J. Virol. 1999, 73(5):4029-4041.
122. Morikawa K., Nonaka M. All-trans-retinoic acid accelerates the differentiation of human B lymphocytes maturing into plasma cells. Int. Immunopharmacol. 2005, 5(13-14):1830-1838.
123. Morrison T.E., Kenney S.C. BZLF1, an Epstein-Barr virus immediate-early protein, induces p65 nuclear translocation while inhibiting p65 transcriptional function. Virology 2004, 328(2):219-232.
124. Morrison T.E., Mauser A., Wong A., Ting J.P., Kenney S.C. Inhibition of IFN-gamma signaling by an Epstein-Barr virus immediate-early protein. Immunity 2001, 15(5):787-799.
125. Morrison T.E., Mauser A., Klingelhutz A., Kenney S.C. Epstein-Barr virus immediate-early protein BZLF1 inhibits tumor necrosis factor alpha-induced signaling and apoptosis by downregulating tumor necrosis factor receptor 1. J. Virol. 2004, 78(1):544-549.
126. Mossalayi M.D., Arock M., Debre P. CD23/Fc epsilon RII: Signaling and clinical implication. Int. Rev. Immunol. 1997, 16(1-2):129-146.
127. Mosser D.M., Zhang X. Interleukin-10: New perspectives on an old cytokine. Immunol. Rev. 2008, 226:205-218.
128. Moustakas A., Pardali K., Gaal A., Heldin C.H. Mechanisms of TGF-beta signaling in regulation of cell growth and differentiation. Immunol. Lett. 2002, 82(1-2):85-91.
129. Muller M., Laxton C., Briscoe J., Schindler C., Improta T., Darnell J.E., Stark G.R., Kerr I.M. Complementation of a mutant cell line: Central role of the 91 kDa polypeptide of ISGF3 in the interferon-alpha and -gamma signal transduction pathways. EMBO J. 1993, 12(11):4221-4228.
130. Nador R.G., Cesarman E., Chadburn A., Dawson D.B., Ansari M.Q., Sald J., Knowles D.M. Primary effusion lymphoma: A distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 1996, 88(2):645-656.
131. Nash A.A., Dutia B.M., Stewart J.P., Davison A.J. Natural history of murine gamma-herpesvirus infection. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2001, 356(1408):569-579.
132. Nicewonger J., Suck G., Bloch D., Swaminathan S. Epstein-Barr virus (EBV) SM protein induces and recruits cellular Sp110b to stabilize mRNAs and enhance EBV lytic gene expression. J. Virol. 2004, 78(17):9412-9422.
133. Page H.G., Read G.S. The virion host shutoff endonuclease (UL41) of herpes simplex virus interacts with the cellular cap-binding complex eIF4F. J. Virol. 2010, 84(13):6886-6890.
134. Pahl H.L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999, 18(49):6853-6866.
135. Pang M.F., Lin K.W., Peh S.C. The signaling pathways of Epstein-Barr virus-encoded latent membrane protein 2A (LMP2A) in latency and cancer. Cell. Mol. Biol. Lett. 2009, 14(2):222-247.
136. Park J., Seo T., Hwang S., Lee D., Gwack Y., Choe J. The K-bZIP protein from Kaposi's sarcoma-associated herpesvirus interacts with p53 and represses its transcriptional activity. J. Virol. 2000, 74(24):11977-11982.
137. Paschoud S., Dogar A.M., Kuntz C., Grisoni-Neupert B., Richman L., Kuhn L.C. Destabilization of interleukin-6 mRNA requires a putative RNA stem-loop structure, an AU-rich element, and the RNA-binding protein AUF1. Mol. Cell. Biol. 2006, 26(22):8228-8241.
138. Persson L.M., Wilson A.C. Wide-Scale Use of Notch Signaling Factor CSL/RBP-J kappa in RTA-Mediated Activation of Kaposi's Sarcoma-Associated Herpesvirus Lytic Genes. J. Virol. 2010, 84(3):1334-1347.
139. Pitti R.M., Marsters S.A., Lawrence D.A., Roy M., Kischkel F.C., Dowd P., Huang A., Donahue C.J., Sherwood S.W., Baldwin D.T., Godowski P.J., Wood W.I., et al. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature 1998, 396(6712):699-703.
140. Polson A.G., Huang L., Lukac D.M., Blethrow J.D., Morgan D.O., Burlingame A.L., Ganem D. Kaposi's sarcoma-associated herpesvirus K-bZIP protein is phosphorylated by cyclin-dependent kinases. J. Virol. 2001, 75(7):3175-3184.
141. Prince S., Keating S., Fielding C., Brennan P., Floettmann E., Rowe M. Latent membrane protein 1 inhibits Epstein-Barr virus lytic cycle induction and progress via different mechanisms. J. Virol. 2003, 77(8):5000-5007.
142. Ragoczy T., Heston L., Miller G. The Epstein-Barr virus Rta protein activates lytic cycle genes and can disrupt latency in B lymphocytes. J. Virol. 1998, 72(10):7978-7984.
143. Rickinson A.B., Kieff E. Epstein-Barr virus. Fields Virology 2007, Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia. 5th Edn. B.N. Fields, D.M. Knipe, P.M. Howley (Eds.).
144. Roan F., Inoue N., Offermann M.K. Activation of cellular and heterologous promoters by the human herpesvirus 8 replication and transcription activator. Virology 2002, 301(2):293-304.
145. Rodriguez A., Armstrong M., Dwyer D., Flemington E. Genetic dissection of cell growth arrest functions mediated by the Epstein-Barr virus lytic gene product Zta. J. Virol. 1999, 73(11):9029-9038.
146. Rodriguez A., Jung E.J., Yin Q., Cayrol C., Flemington E.K. Role of c-myc regulation in Zta-mediated induction of the cyclin-dependent kinase inhibitors p21 and p27 and cell growth arrest. Virology 2001, 284(2):159-169.
147. Roubal J., Luka J., Klein G. Effect of retinoic acid (RA) on the Epstein-Barr virus (EBV)-inducing effect of sodium butyrate. Cancer Lett. 1980, 8(3):209-212.
148. Rowe M., Glaunsinger B., van Leeuwen D., Zuo J., Sweetman D., Ganem D., Middeldorp J., Wiertz E.J., Ressing M.E. Host shutoff during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasion. Proc. Natl. Acad. Sci. USA 2007, 104(9):3366-3371.
149. Roy M., Pear W.S., Aster J.C. The multifaceted role of Notch in cancer. Curr. Opin. Genet. Dev. 2007, 17(1):52-59.
150. Ruvolo V., Navarro L., Sample C.E., David M., Sung S., Swaminathan S. The Epstein-Barr virus SM protein induces STAT1 and interferon-stimulated gene expression. J. Virol. 2003, 77(6):3690-3701.
151. Salaun C., Macdonald A.I., Larralde O., Howard L., Lochtie K., Burgess H.M., Brook M., Malik P., Gray N.K., Graham S.V. Poly(A)-binding protein 1 (PABP1) partially relocalises to the nucleus during HSV-1 infection in an ICP27-independent manner and does not inhibit virus replication. J. Virol. 2010, 84(17):8539-8548.
152. Sandri-Goldin R.M. The many roles of the regulatory protein ICP27 during herpes simplex virus infection. Front. Biosci. 2008, 13:5241-5256.
153. Sarid R., Flore O., Bohenzky R.A., Chang Y., Moore P.S. Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1). J. Virol. 1998, 72(2):1005-1012.
154. Sato Y., Kamura T., Shirata N., Murata T., Kudoh A., Iwahori S., Nakayama S., Isomura H., Nishiyama Y., Tsurumi T. Degradation of phosphorylated p53 by viral protein-ECS E3 ligase complex. PLoS Pathog. 2009, 5(7):e1000530.
155. Sato Y., Shirata N., Kudoh A., Iwahori S., Nakayama S., Murata T., Isomura H., Nishiyama Y., Tsurumi T. Expression of Epstein-Barr virus BZLF1 immediate-early protein induces p53 degradation independent of MDM2, leading to repression of p53-mediated transcription. Virology 2009, 388(1):204-211.
156. Sato Y., Shirata N., Murata T., Nakasu S., Kudoh A., Iwahori S., Nakayama S., Chiba S., Isomura H., Kanda T., Tsurumi T. Transient increases in p53-responsible gene expression at early stages of Epstein-Barr virus productive replication. Cell Cycle 2010, 9(4):807-814.
157. Scala G., Quinto I., Ruocco M.R., Arcucci A., Mallardo M., Caretto P., Forni G., Venuta S. Expression of an exogenous interleukin 6 gene in human Epstein Barr virus B cells confers growth advantage and in vivo tumorigenicity. J. Exp. Med. 1990, 172(1):61-68.
158. Schelcher C., Valencia S., Delecluse H.J., Hicks M., Sinclair A.J. Mutation of a single amino acid residue in the basic region of the Epstein-Barr virus (EBV) lytic cycle switch protein Zta (BZLF1) prevents reactivation of EBV from latency. J. Virol. 2005, 79(21):13822-13828.
159. Schwarzmeier J.D., Hubmann R., Duchler M., Jager U., Shehata M. Regulation of CD23 expression by Notch2 in B-cell chronic lymphocytic leukemia. Leuk. Lymphoma 2005, 46(2):157-165.
160. Sergeant A., Gruffat H., Manet E. The Epstein-Barr virus (EBV) protein EB2 is an mRNA export factor essential for virus production. Front. Biosci. 2008, 13:3798-3813.
161. Sheaff R.J., Groudine M., Gordon M., Roberts J.M., Clurman B.E. Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev. 1997, 11(11):1464-1478.
162. Simas J.P., Efstathiou S. Murine gammaherpesvirus 68: A model for the study of gammaherpesvirus pathogenesis. Trends Microbiol. 1998, 6(7):276-282.
163. Sinclair A.J. bZIP proteins of human gammaherpesviruses. J. Gen. Virol. 2003, 84(Pt 8):1941-1949.
164. Sista N.D., Pagano J.S., Liao W., Kenney S. Retinoic acid is a negative regulator of the Epstein-Barr virus protein (BZLF1) that mediates disruption of latent infection. Proc. Natl. Acad. Sci. USA 1993, 90(9):3894-3898.
165. Steed A.L., Barton E.S., Tibbetts S.A., Popkin D.L., Lutzke M.L., Rochford R., Virgin H.W. Gamma interferon blocks gammaherpesvirus reactivation from latency. J. Virol. 2006, 80(1):192-200.
166. Swaminathan S. Post-transcriptional gene regulation by gamma herpesviruses. J. Cell. Biochem. 2005, 95(4):698-711.
167. Swaminathan S. Noncoding RNAs produced by oncogenic human herpesviruses. J. Cell. Physiol. 2008, 216(2):321-326.
168. Swaminathan S., Kenney S. The Epstein-Barr virus lytic life cycle. DNA Tumor Viruses 2009, 285-315. Springer Science/Business Media, New York. B. Damania, J.M. Pipas (Eds.).
169. Swenson J.J., Mauser A.E., Kaufmann W.K., Kenney S.C. The Epstein-Barr virus protein BRLF1 activates S phase entry through E2F1 induction. J. Virol. 1999, 73(8):6540-6550.
170. Takaoka A., Yanai H. Interferon signalling network in innate defence. Cell. Microbiol. 2006, 8(6):907-922.
171. Tang S., Zheng Z.M. Kaposi's sarcoma-associated herpesvirus K8 exon 3 contains three 5'-splice sites and harbors a K8.1 transcription start site. J. Biol. Chem. 2002, 277(17):14547-14556.
172. Tanner J., Tosato G. Impairment of natural killer functions by interleukin 6 increases lymphoblastoid cell tumorigenicity in athymic mice. J. Clin. Investig. 1991, 88(1):239-247.
173. Thiel G., Cibelli G. Regulation of life and death by the zinc finger transcription factor Egr-1. J. Cell. Physiol. 2002, 193(3):287-292.
174. Tomita M., Choe J., Tsukazaki T., Mori N. The Kaposi's sarcoma-associated herpesvirus K-bZIP protein represses transforming growth factor beta signaling through interaction with CREB-binding protein. Oncogene 2004, 23(50):8272-8281.
175. Tsai S.C., Lin S.J., Chen P.W., Luo W.Y., Yeh T.H., Wang H.W., Chen C.J., Tsai C.H. EBV Zta protein induces the expression of interleukin-13, promoting the proliferation of EBV-infected B cells and lymphoblastoid cell lines. Blood 2009, 114(1):109-118.
176. van Boxel-Dezaire A.H., Stark G.R. Cell type-specific signaling in response to interferon-gamma. Curr. Top. Microbiol. Immunol. 2007, 316:119-154.
177. Verma D., Swaminathan S. Epstein-Barr virus SM protein functions as an alternative splicing factor. J. Virol. 2008, 82(14):7180-7188.
178. Wang Y., Yuan Y. Essential role of RBP-J kappa in activation of the K8 delayed-early promoter of Kaposi's sarcoma-associated herpesvirus by ORF50/RTA. Virology 2007, 359(1):19-27.
179. Wilkinson D.E., Weller S.K. The role of DNA recombination in herpes simplex virus DNA replication. IUBMB Life 2003, 55(8):451-458.
180. Wu F.Y., Tang Q.Q., Chen H., ApRhys C., Farrell C., Chen J., Fujimuro M., Lane M.D., Hayward G.S. Lytic replication-associated protein (RAP) encoded by Kaposi sarcoma-associated herpesvirus causes p21CIP-1-mediated G1 cell cycle arrest through CCAAT/enhancer-binding protein-alpha. Proc. Natl. Acad. Sci. USA 2002, 99(16):10683-10688.
181. Wu F.Y., Chen H., Wang S.E., ApRhys C.M., Liao G., Fujimuro M., Farrell C.J., Huang J., Hayward S.D., Hayward G.S. CCAAT/enhancer binding protein alpha interacts with ZTA and mediates ZTA-induced p21(CIP-1) accumulation and G(1) cell cycle arrest during the Epstein-Barr virus lytic cycle. J. Virol. 2003, 77(2):1481-1500.
182. Wu F.Y., Wang S.E., Tang Q.Q., Fujimuro M., Chiou C.J., Zheng Q., Chen H., Hayward S.D., Lane M.D., Hayward G.S. Cell cycle arrest by Kaposi's sarcoma-associated herpesvirus replication-associated protein is mediated at both the transcriptional and posttranslational levels by binding to CCAAT/enhancer-binding protein alpha and p21(CIP-1). J. Virol. 2003, 77(16):8893-8914.
183. Yada K., Do E., Sakakibara S., Ohsaki E., Ito E., Watanabe S., Ueda K. KSHV RTA induces a transcriptional repressor, HEY1 that represses rta promoter. Biochem. Biophys. Res. Commun. 2006, 345(1):410-418.
184. Yamanegi K., Tang S., Zheng Z.M. Kaposi's sarcoma-associated herpesvirus K8beta is derived from a spliced intermediate of K8 pre-mRNA and antagonizes K8alpha (K-bZIP) to induce p21 and p53 and blocks K8alpha-CDK2 interaction. J. Virol. 2005, 79(22):14207-14221.
185. Yu K.Y., Kwon B., Ni J., Zhai Y., Ebner R., Kwon B.S. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J. Biol. Chem. 1999, 274(20):13733-13736.
186. Yu Y.X., Wang S.Z.E., Hayward G.S. The KSHV immediate-early transcription factor RTA encodes ubiquitin E3 ligase activity that targets IRF7 for proteosome-mediated degradation. Immunity 2005, 22(1):59-70.
187. Zacny V.L., Wilson J., Pagano J.S. The Epstein-Barr virus immediate-early gene product, BRLF1, interacts with the retinoblastoma protein during the viral lytic cycle. J. Virol. 1998, 72(10):8043-8051.
188. Zalani S., Holley-Guthrie E., Kenney S. Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism. Proc. Natl. Acad. Sci. USA 1996, 93(17):9194-9199.
189. Zeng Y., Zhou H.M., Xu S.P. Inhibitory effect of retinoids on Epstein-Barr virus induction in Raji cells. Intervirology 1981, 16(1):29-32.
190. Zhang L., Pagano J.S. Structure and function of IRF-7. J. Interferon Cytokine Res. 2002, 22(1):95-101.
191. Zhang Q., Gutsch D., Kenney S. Functional and physical interaction between p53 and BZLF1: Implications for Epstein-Barr virus latency. Mol. Cell. Biol. 1994, 14(3):1929-1938.
192. Zhang J., Wang J., Wood C., Xu D., Zhang L. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 replication and transcription activator regulates viral and cellular genes via interferon-stimulated response elements. J. Virol. 2005, 79(9):5640-5652.
193. Zhu F.X., King S.M., Smith E.J., Levy D.E., Yuan Y. A Kaposi's sarcoma-associated herpesviral protein inhibits virus-mediated induction of type I interferon by blocking IRF-7 phosphorylation and nuclear accumulation. Proc. Natl. Acad. Sci. USA 2002, 99(8):5573-5578.
194. Zhu H., Nie L., Maki C.G. Cdk2-dependent Inhibition of p21 stability via a C-terminal cyclin-binding motif. J. Biol. Chem. 2005, 280(32):29282-29288.
195. Zimber-Strobl U., Strobl L.J. EBNA2 and Notch signalling in Epstein-Barr virus mediated immortalization of B lymphocytes. Semin. Cancer Biol. 2001, 11(6):423-434.
196. Zuo J., Thomas W., van Leeuwen D., Middeldorp J.M., Wiertz E.J., Ressing M.E., Rowe M. The DNase of gammaherpesviruses impairs recognition by virus-specific CD8+ T cells through an additional host shutoff function. J. Virol. 2008, 82(5):2385-2393.
197. Zuo J., Currin A., Griffin B.D., Shannon-Lowe C., Thomas W.A., Ressing M.E., Wiertz E.J., Rowe M. The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradation. PLoS Pathog. 2009, 5(1):e1000255.
198. Zurawski G., de Vries J.E. Interleukin 13 elicits a subset of the activities of its close relative interleukin 4. Stem Cells 1994, 12(2):169-174.